Noile-Immune Biotech (TSE:4893) Total Current Assets : 円5,395.6 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Noile-Immune Biotech Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Noile-Immune Biotech's total current assets for the quarter that ended in Mar. 2024 was 円5,395.6 Mil.

Noile-Immune Biotech Total Current Assets Historical Data

The historical data trend for Noile-Immune Biotech's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noile-Immune Biotech Total Current Assets Chart

Noile-Immune Biotech Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Total Current Assets

2,659.09

4,225.37

4,584.18

5,717.09

Noile-Immune Biotech Quarterly Data
	Dec20	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Current Assets	Get a 7-Day Free Trial				-	6,070.32	6,106.33	5,717.09	5,395.56

Noile-Immune Biotech Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Noile-Immune Biotech's Total Current Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	5555.691	+	0	+	20.901	+	140.497
	=	5,717.1

Noile-Immune Biotech's Total Current Assets for the quarter that ended in Mar. 2024 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	5240.477	+	0	+	16.58	+	138.499
	=	5,395.6

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Noile-Immune Biotech (TSE:4893) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Noile-Immune Biotech's Liquidation Value for the quarter that ended in Mar. 2024 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	5240.477	-	107.217	+	0.75 * 0	+	0.5 * 16.58
=	5,141.6

Noile-Immune Biotech Total Current Assets Related Terms

Thank you for viewing the detailed overview of Noile-Immune Biotech's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Noile-Immune Biotech (TSE:4893) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Noile-Immune Biotech Inc (TSE:4893) » Definitions » Total Current Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

2-12-10 Shiba-Daimon, Minato-ku, Tokyo, JPN, 105-0012

Website

https://www.noile-immune.com

Noile-Immune Biotech Inc is engaged in the development of novel cancer immunotherapy including CAR-T cell therapy.

Noile-Immune Biotech (TSE:4893) Headlines

No Headlines